Quantinuum (NASDAQ:QNT) Raised to “Strong-Buy” at Cantor Fitzgerald

Quantinuum (NASDAQ:QNTGet Free Report) was upgraded by analysts at Cantor Fitzgerald to a “strong-buy” rating in a research note issued to investors on Monday,Zacks.com reports.

Other equities analysts also recently issued research reports about the company. TD Cowen initiated coverage on Quantinuum in a research note on Monday. They set a “buy” rating for the company. Mizuho assumed coverage on Quantinuum in a report on Monday. They issued an “outperform” rating and a $90.00 target price on the stock. Craig Hallum started coverage on Quantinuum in a research report on Monday. They set a “buy” rating and a $100.00 target price on the stock. Needham & Company LLC assumed coverage on Quantinuum in a report on Monday. They set a “buy” rating and a $100.00 price target for the company. Finally, Wall Street Zen raised Quantinuum to a “hold” rating in a research report on Saturday, June 20th. Three analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat, Quantinuum currently has an average rating of “Buy” and a consensus price target of $98.75.

View Our Latest Stock Report on Quantinuum

Quantinuum Stock Performance

NASDAQ:QNT opened at $72.84 on Monday. Quantinuum has a one year low of $50.10 and a one year high of $81.48.

Insider Transactions at Quantinuum

In other Quantinuum news, Director Kenneth D. Denman purchased 14,000 shares of the firm’s stock in a transaction that occurred on Friday, June 5th. The stock was bought at an average cost of $60.00 per share, with a total value of $840,000.00. Following the completion of the transaction, the director owned 19,833 shares of the company’s stock, valued at $1,189,980. The trade was a 240.01% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Michal Stepniak purchased 13,333 shares of the company’s stock in a transaction that occurred on Friday, June 5th. The shares were acquired at an average price of $60.00 per share, for a total transaction of $799,980.00. Following the completion of the acquisition, the director directly owned 13,333 shares of the company’s stock, valued at $799,980. This trade represents a ∞ increase in their position. The SEC filing for this purchase provides additional information. In the last 90 days, insiders have bought 411,032 shares of company stock worth $24,661,920.

Key Stories Impacting Quantinuum

Here are the key news stories impacting Quantinuum this week:

  • Positive Sentiment: Multiple firms initiated coverage on Quantinuum with bullish calls, including JPMorgan, Rosenblatt, Craig Hallum, Bank of America, Needham, Mizuho, and Sanford C. Bernstein, with several price targets implying meaningful upside. Analyst coverage and price targets
  • Positive Sentiment: Rosenblatt was the most bullish, assigning a buy rating and a $155 target, signaling strong confidence in Quantinuum’s long-term growth potential. Rosenblatt coverage
  • Positive Sentiment: Congressional trading activity also drew attention after Rep. Cleo Fields reportedly made a new quantum-related bet, adding to investor interest in the sector. Congressman Who Buys Magnificent Seven Stocks With Size Made New Quantum Bet
  • Neutral Sentiment: Morgan Stanley initiated coverage with an equal weight rating and a $78 target, which is more cautious than peers but still above the recent trading level. Morgan Stanley coverage
  • Negative Sentiment: Despite the bullish analyst wave, the stock has been falling, suggesting investors may be taking profits or reacting to valuation concerns after the sharp run-up in interest around quantum computing. Quantinuum stock falls: why is Wall Street bullish on the stock?

About Quantinuum

(Get Free Report)

Quantinuum is a quantum computing company focused on developing hardware and software for commercial and scientific applications. The company provides access to its quantum systems, along with software tools and services designed to help customers explore use cases in areas such as optimization, materials science, chemistry, cybersecurity, and machine learning.

The company was formed through the combination of Honeywell Quantum Solutions and Cambridge Quantum in 2021. Quantinuum operates internationally and serves a range of customers across enterprise, government, and research markets.

Further Reading

Analyst Recommendations for Quantinuum (NASDAQ:QNT)

Receive News & Ratings for Quantinuum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantinuum and related companies with MarketBeat.com's FREE daily email newsletter.